Editorial

3-D Printing/Additive Mfg.

Additive Manufacturing at the Point of Care (Revisited)

Whether using it for a prototype, a replacement part, or just for fun, AM is only limited by the user’s imagination.

Sean Fenske, Editor-in-Chief 05.23.23

Biologics

A More Natural Future Using Biologics?

Will all of orthopedics embrace technologies that promote a more natural healing protocol?

Sean Fenske, Editor-in-Chief 03.10.23

Will the EU Medical Device Shortage Be Delayed?

The new deadline for the transition, under the proposal, would be Dec. 31 in 2027 or 2028.

Sean Fenske, Editor-in-Chief 02.15.23

A 2023 To-Do List for the Orthopedic Industry

What are the top priorities on your to-do list?

Sean Fenske, Editor-in-Chief 11.15.22

Realizing the Point of Developing Smart Implants

The promise of smart implants has yet to be realized but the Persona IQ marks a significant first step.

Sean Fenske, Editor-in-Chief 09.16.22

Supply Chain

Orthopedic Device OEMs Recover Rapidly to Face Supply Chain Challenges

ODT's Top Company reports reveal a recovery for orthopedic device makers, but now they face a supply chain crisis.

Sean Fenske, Editor-in-Chief 08.12.22

Getting a Glance at Innovative Technology…Again

There's no better setting to discover new orthopedic device innovation than the AAOS annual meeting.

Sean Fenske, Editor-in-Chief 05.26.22

A New Top 10 Member (well, for next year anyway)

It should be exciting to see how the new player ZimVie impacts the market.

Sean Fenske, Editor-in-Chief 03.24.22

Why Memphis? An ODT Forum Preview

There are a number of reasons Memphis makes for a perfect location for the ODT Forum.

Sean Fenske, Editor-in-Chief 02.14.22

Orthopedics Device Industry: 2021 Review and 2022 Expectations

The end of a year marks a time to take a moment to reflect on what’s happened and what’s potentially coming.

Sean Fenske, Editor-in-Chief 11.17.21

CMS Changes Create Uncertainty for ASCs, Orthopedics, and Patients

The flip-flop by CMS on the elimination of the Inpatient Only list has created questions regarding what procedures will be available where.

Sean Fenske, Editor-in-Chief 09.14.21

Thoughts and Observations from the 2021 Top Companies Reports

The Top Companies Report is always a fantastic way to catch up with what was happening at the leading firms in the industry in their most recent fiscal.

Sean Fenske, Editor-in-Chief 08.17.21

Is Orthopedics on the Road to Pandemic Recovery?

The quarterly reports from orthopedic device makers paint a positive picture in terms of a recovery within the technology sector.

Sean Fenske, Editor-in-Chief 05.17.21

Hyaluronic Acid: Drug or Device?

In December 2018, the agency issued a Notice in the Federal Register that it was considering a change in how HA was classified.

Sean Fenske, Editor-in-Chief 03.16.21

Dusting Off the Hidden Gems

An update on the previously identified orthopedic 'diamonds in the rough' companies.

Sean Fenske, Editor-in-Chief 02.08.21

The Lingering Impact of COVID-19

There are lessons to be learned from this experience and there could even be elements that cause a lasting change regarding the orthopedic industry.

Sean Fenske, Editor-in-Chief 11.18.20

Launching ODT: A Look Back

In anticipation of ODT's 15th anniversary, I took time to speak with the only two members of the team who were around at the time of its birth.

Sean Fenske, Editor-in-Chief 09.15.20

MIS/Robotics

Orthopedic’s Future with Robotics and AI

Robotic surgical systems coupled with artificial intelligence could make for a very interesting future for the orthopedic industry.

Sean Fenske, Editor-in-Chief 08.11.20

Extremities | Large Joint | Spine/Neurology

Return of Elective Surgeries in a COVID-19 Environment

What's going to happen in the second half of the year or fourth quarter when hospitals and surgery centers are ramping up for a higher volume of procedures?

Sean Fenske, Editor-in-Chief 05.20.20